Mumbai: Woman Held For Selling Fake Cancer Drugs

Mumbai : The Crime Branch (CB) Control on Thursday arrested a 30-year-old woman from Kalyan for selling spurious medicines in the name of genuine Adcetris injection and Iclusig tablet used in cancer patients’ treatment.

The value of the spurious medicines is estimated to be over Rs 67 lakh. The genuine medicines are manufactured by a Japanese company whose representative lodged a police complaint.

The accused, Pooja Rana, owns Prime Pharma, a pharmaceutical company located in Kalyan. She was produced before a court on Friday and remanded in police custody till October 4.

Inspector Nitin Patil of the CB Control, a unit of the city Economic Offences Wing, said, “The Japanese company has appointed an Indian firm to take legal action if they find intellectual property rights violations concerninh their products. We were informed about the sale of these fake products in March. A trap was laid and one Adcetris injection was purchased for Rs.1.12 lakh in Santacruz through Prime Pharma. The seized product was sent for forensic analysis, and the report stated that it was fake and was not manufactured by the Japanese company concerned,” said a police source. The actual price of a genuine injection is Rs 5.80 lakh.

Based on the forensic report, a case was registered under various sections of the IPC and Copyright Act at the Santacruz police station on Thursday and the probe was transferred to the EOW.

A police team arrived at Prime Pharma’s office in Kalyan and during search it seized six fake Adcetris injections and two Iclusig tablets. Rana was arrested.

“These medicines are not manufactured in India, and can be imported only through a proper licence. The accused was was selling such spurious medicines which could harm human lives,” said Niket Kaushik, EOW chief.

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise